Tissue distribution of inhaled micro- and nano-sized cerium oxide particles in rats: results from a 28-day exposure study.
about
Acute inflammatory responses of nanoparticles in an intra-tracheal instillation rat modelSilica coating influences the corona and biokinetics of cerium oxide nanoparticlesThe yin: an adverse health perspective of nanoceria: uptake, distribution, accumulation, and mechanisms of its toxicityPulmonary cerium dioxide nanoparticle exposure differentially impairs coronary and mesenteric arteriolar reactivityIntravenous and gastric cerium dioxide nanoparticle exposure disrupts microvascular smooth muscle signalingPotential toxicity of engineered nanoparticles in mammalian germ cells and developing embryos: treatment strategies and anticipated applications of nanoparticles in gene deliveryPhysicochemical characteristics of nanomaterials that affect pulmonary inflammationCentral nervous system toxicity of metallic nanoparticlesInhaled diesel emissions generated with cerium oxide nanoparticle fuel additive induce adverse pulmonary and systemic effectsToxicity of Two Different Sized Lanthanum Oxides in Cultured Cells and Sprague-Dawley RatsIn vivo biodistribution and physiologically based pharmacokinetic modeling of inhaled fresh and aged cerium oxide nanoparticles in ratsTime course of lung retention and toxicity of inhaled particles: short-term exposure to nano-CeriaChanges in cardiopulmonary function induced by nanoparticlesApplication of dental nanomaterials: potential toxicity to the central nervous systemParticle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticlesToxicological Evaluations of Rare Earths and Their Health Impacts to Workers: A Literature ReviewGenotoxicity of synthetic amorphous silica nanoparticles in rats following short-term exposure. Part 2: intratracheal instillation and intravenous injection.Effects from a 90-day inhalation toxicity study with cerium oxide and barium sulfate nanoparticles in rats.Engineered nanomaterials: an emerging class of novel endocrine disruptorsProgress and future of in vitro models to study translocation of nanoparticles.Slow lung clearance and limited translocation of four sizes of inhaled iridium nanoparticles.Granular biodurable nanomaterials: No convincing evidence for systemic toxicity.Differences in physicochemical properties to consider in the design, evaluation and choice between microparticles and nanoparticles for drug delivery.Nanomaterial translocation--the biokinetics, tissue accumulation, toxicity and fate of materials in secondary organs--a review.Preparation, characterization, and in vitro dosimetry of dispersed, engineered nanomaterials.Cerium oxide nanoparticles in neuroprotection and considerations for efficacy and safety.Multiwalled carbon nanotubes hinder microglia function interfering with cell migration and phagocytosis.Acute changes in murine hippocampus and olfactory bulb after nasal instillation of varying size cerium dioxide particles.Cerium dioxide nanoparticles affect in vitro fertilization in mice.A novel synthetic approach of cerium oxide nanoparticles with improved biomedical activity.Pulmonary distribution of nanoceria: comparison of intratracheal, microspray instillation and dry powder insufflation.One time nose-only inhalation of MWCNTs: Exploring the mechanism of toxicity by intermittent sacrifice in Wistar rats.Molecular mechanism of oxidative damage of lung in mice following exposure to lanthanum chloride.Toxicity and bio-accumulation of inhaled cerium oxide nanoparticles in CD1 mice.Rat hippocampal responses up to 90 days after a single nanoceria dose extends a hierarchical oxidative stress model for nanoparticle toxicity.Pulmonary toxicity in mice following exposure to cerium chloride.Metabolomic effects of CeO2, SiO2 and CuO metal oxide nanomaterials on HepG2 cells.Biokinetics of Nanomaterials: the Role of Biopersistence.The effect of zirconium doping of cerium dioxide nanoparticles on pulmonary and cardiovascular toxicity and biodistribution in mice after inhalation.Genotoxicity analysis of cerium oxide micro and nanoparticles in Wistar rats after 28 days of repeated oral administration.
P2860
Q23909870-98B6B063-2BED-4C33-9396-D2A648D429C7Q23918710-CEA944E1-270D-4150-9562-7C447B3C8B3CQ23920228-AF6B3B1B-6B02-4F4F-A294-FB06FA085C33Q23923197-BB8F028E-7F30-48A8-935F-950CE38690F8Q23923199-D86AB928-D8A3-4DD9-A952-E3D3960D0C7CQ26744195-E9386818-233C-4FE5-A849-9D73721645AAQ26859438-A7AF09CA-FCA0-4D71-95E7-290B7B23F5B9Q28084729-111CFC3C-118D-4E60-A18F-6E021B23BC39Q28383351-267ACCC7-71B4-4865-8911-F171465856D2Q28383698-D6707743-9309-4FB9-9282-867FB68DA484Q28387077-6290C9D8-9146-4B85-A037-16C83ADA8AACQ28387293-5709D6A8-39AE-436A-9BC7-C39606DE6377Q28389900-48AA9DCB-32E2-493A-942F-4C34F73B6399Q28394487-62EAC873-F203-42E2-AE00-9DB69D192AA9Q29248667-EC797CCF-0CB8-412E-8909-03B027B646F0Q29544940-F459E986-1123-4EAF-80C7-172847874830Q33419032-0EF1DF4B-34CD-4579-9351-495D0FCA1396Q33901229-0303B51A-8474-4F10-8202-6849ADF31C56Q35617228-98C6F12E-B805-43FF-9C42-57721CC0E7A4Q36001471-97ABF149-F8D4-4A6A-B99E-B00AC27B0EB4Q36277388-E5C15ED6-5ED5-4E38-B819-831A792B40D7Q38254509-4BDFE78B-B237-4576-9524-1F8BF7A6C3C3Q38291341-CC50369D-7AF8-471A-9B8F-76EA27850F51Q38542397-E9A8EA33-6C79-4EF5-A0F7-B5EABDBBC487Q38720595-085B5E27-9BCB-4B9E-A245-B141890B08BEQ38793842-D6F05493-175E-4FEC-897B-8454E148882BQ39109693-941418DE-361A-4EE7-BB98-934A1514A627Q39418830-D728C6ED-E544-4BDE-AD9A-144B50BDCB06Q40911272-9845A488-3FDC-4562-8361-D7BAC19148B8Q40957180-4BB70680-608B-4BC8-96BA-07E56E0BE216Q41644014-B51869EB-F6B3-4524-9A32-461B5387A898Q41680531-921C49CD-5A3A-45B8-8870-806AF2C57CEDQ42708810-532581DF-B314-474D-A132-1D17DEEFA59AQ45213989-6216DA30-A549-47D6-9A09-E605602C5559Q46567213-4D6E4720-3EB0-4F22-A3F6-54B1200F0F13Q46905162-58C8DBF5-C5A8-4361-86F3-8153B3133D90Q47144436-C3267342-16C2-4EC2-86F1-F1C9843DE0A8Q47745983-719E29B1-BAC1-422C-8679-619EC300E1BEQ48350830-C14AF1CB-ECD0-4C7A-B38B-AAED19B82B38Q48550978-F328AE24-EE2F-4E48-93E8-84FEA4F8CBC4
P2860
Tissue distribution of inhaled micro- and nano-sized cerium oxide particles in rats: results from a 28-day exposure study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Tissue distribution of inhaled ...... from a 28-day exposure study.
@en
Tissue distribution of inhaled ...... from a 28-day exposure study.
@nl
type
label
Tissue distribution of inhaled ...... from a 28-day exposure study.
@en
Tissue distribution of inhaled ...... from a 28-day exposure study.
@nl
prefLabel
Tissue distribution of inhaled ...... from a 28-day exposure study.
@en
Tissue distribution of inhaled ...... from a 28-day exposure study.
@nl
P2093
P2860
P356
P1476
Tissue distribution of inhaled ...... s from a 28-day exposure study
@en
P2093
Agnes G Oomen
Flemming R Cassee
Jeffry D Schroeter
Liesbeth Geraets
P2860
P304
P356
10.1093/TOXSCI/KFS113
P577
2012-03-19T00:00:00Z